Malkhaz Mizandari

TL;DR: A novel injectable saRNA‐oligonucleotide that enhances C/EBPα expression successfully reduces tumor burden and simultaneously improves liver function in a clinically relevant liver cirrhosis/HCC model.

TL;DR: In this group of patients, it appears that this new approach to radiofrequency ablation of malignant biliary obstruction is feasible and safe and remains to be proven in future, randomized, prospective studies.

TL;DR: In this paper, the authors reviewed all studies with imaging findings presentation of lymphadenopathy (LAP) after COVID-19 vaccination and found that LAP was identified after first or second dosages of three types of COVID19 vaccines, including Pfizer-BioNTech (nâ´¯=â´30, 44.1%), Moderna (n´18, 25%), and Oxford-AstraZeneca (n`18, 1.5%).

TL;DR: The percutaneous RF based ablation of obstructed bile duct and PD with metallic stent placement appeared to be a safe, effective procedure and may improve survival in patients with advanced stage cancer presenting with biliary and PD obstruction.

TL;DR: Study have shown that decrease in the NLR, PLR and expression of CD4+CD39+ on T lymphocytes as the marker of better survival in hepatic cancer patients and findings have confirmed that these changes can be induced following application of RF energy.